Incidencia de mucositis periimplantaria en pacientes con periodontititis tratada: resultados a los 12 meses
Loading...
Official URL
Full text at PDC
Publication date
2024
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Citation
Abstract
ANTECEDENTES La mucositis periimplantaria es una de las patologías asociadas al tejido blando periimplantario más comunes. El factor etiológico principal es la acumulación de biofilm alrededor del implante. Los estudios que evalúan su incidencia son escasos, aún más sobre pacientes con historia de periodontitis tratada. Además, los estudios presentes emplean distintas definiciones que aumentan la heterogeneidad de resultados.
OBJETIVOS Analizar la incidencia de mucositis periimplantaria acumulada sobre sujetos con periodontitis tratada. Registrar múltiples variables que podrían estar asociadas a una mayor incidencia de la patología.
MATERIAL Y MÉTODOS Se presentan resultados preliminares de 26 sujetos que han completado el seguimiento de 12 meses pertenecientes al estudio “Incidencia de mucositis periimplantaria en pacientes con periodontitis tratada: estudio prospectivo” llevado a cabo en la sección de periodoncia de la Facultad de Odontología de la Universidad Complutense de Madrid. Se analiza la variable principal que corresponde con la incidencia de mucositis periimplantaria a los 12 meses así como diferentes variables secundarias (sociodemográficas, historia dental, procedimiento quirúrgico, relacionadas con la prótesis, reportadas por los pacientes y morfológicas del tejido blando periimplantario en anchura, altura y grosor).
RESULTADOS La incidencia de mucositis periimplantaria a los 12 meses de seguimiento fue del 81% a nivel sujeto y del 62% a nivel implante con la definición que se establece en el Workshop Europeo del 2017, en cambio, mediante la definición propuesta por la guía de práctica clínica nivel S3 de la EFP en 2023 se obtuvo una incidencia del 67% a nivel sujeto y del 46% a nivel implante.
CONCLUSIONES La incidencia de mucositis periimplantaria varía ampliamente según la definición que se utilice. Aún así, la incidencia de la patología es alta variando desde el 81% al 67% a nivel sujeto y del 62% al 46% a nivel implante.
BACKGROUND Peri-implant mucositis is one of the most common soft tissue pathologies associated with peri-implant tissues. The primary etiological factor is the accumulation of biofilm around the implant. Available studies evaluating its incidence are scarce, particularly those focusing on patients with history of treated periodontitis. Even more, available studie employ different definitions, which increases the heterogeneity of the results. OBJECTIVES Analyze the cumulative incidence of peri-implant mucositis in individuals with treated periodontitis and record different variables that could be associated with a higher incidence of the pathology. MATERIALS AND METHODS Preliminary results are presented from 26 subjects who have completed the 12 months follow-up in the study “Incidence of peri-implant mucositis in patients with treated periodontitis: A Prospective Study” conducted in the Periodontics section of the Faculty of Dentistry at the Complutense University of Madrid. The primary variable analyzed was the incidence of peri-implant mucositis at 12 months. Furthermore, some secondary variables were recorded (sociodemographic, dental history, surgical procedure, prosthesis-related variables, patient-reported outcomes and morphological characteristics of the peri-implant soft tissue such as width, height and thickness). RESULTS The incidence of peri-implant mucositis after 12 months of follow-up was 81% at subject level and 62% at implant level according to the definition established in the 2017 European Workshop. However, using the definition presented by the S3 level Clinical Practice Guideline of the EFP in 2023, the incidence was 67% at subject level and 46% at implant level. CONCLUSIONS The incidence of peri-implant mucositis changes widely depending on the definition used. Nevertheless, the incidence of the pathology remains high, ranging from 81% to 67% at subject level and from 62% to 46% at implant level.
BACKGROUND Peri-implant mucositis is one of the most common soft tissue pathologies associated with peri-implant tissues. The primary etiological factor is the accumulation of biofilm around the implant. Available studies evaluating its incidence are scarce, particularly those focusing on patients with history of treated periodontitis. Even more, available studie employ different definitions, which increases the heterogeneity of the results. OBJECTIVES Analyze the cumulative incidence of peri-implant mucositis in individuals with treated periodontitis and record different variables that could be associated with a higher incidence of the pathology. MATERIALS AND METHODS Preliminary results are presented from 26 subjects who have completed the 12 months follow-up in the study “Incidence of peri-implant mucositis in patients with treated periodontitis: A Prospective Study” conducted in the Periodontics section of the Faculty of Dentistry at the Complutense University of Madrid. The primary variable analyzed was the incidence of peri-implant mucositis at 12 months. Furthermore, some secondary variables were recorded (sociodemographic, dental history, surgical procedure, prosthesis-related variables, patient-reported outcomes and morphological characteristics of the peri-implant soft tissue such as width, height and thickness). RESULTS The incidence of peri-implant mucositis after 12 months of follow-up was 81% at subject level and 62% at implant level according to the definition established in the 2017 European Workshop. However, using the definition presented by the S3 level Clinical Practice Guideline of the EFP in 2023, the incidence was 67% at subject level and 46% at implant level. CONCLUSIONS The incidence of peri-implant mucositis changes widely depending on the definition used. Nevertheless, the incidence of the pathology remains high, ranging from 81% to 67% at subject level and from 62% to 46% at implant level.